Predictors and Impact of Thirty-Day Readmission on Patient Outcomes and Health Care Costs after Reduced-Toxicity Conditioning Allogeneic Hematopoietic Cell TransplantationSherri Rauenzahn, Abraham S. Kanate, Sonia Leadmon et al.|Transplantation and Cellular Therapy|2013Cited by 18
Predictors and Impact Of 30-Day Readmissions On Patient Outcomes and Healthcare Costs After Allogeneic Hematopoietic Cell TransplantationAbraham S. Kanate, Mehdi Hamadani, Sherri Rauenzahn et al.|Blood|2013Cited by 0